with muscle activity). As the skin ages, the layers atrophy and become thinner, and elasticity is lost. Dynamic wrinkles are formed through the permanent hypercontractions that occur as compensation for age-related atrophy. 8 A correlation was also found between repetitive facial movements and both dynamic and static facial wrinkles. 9 Amid the high demand among consumers for safe and effective antiaging therapies, a host of strategies are currently available. Mildto-moderate surface wrinkles and other signs of aging can be treated with topical agents, while deeper wrinkles may be managed with on-abotulinumtoxinA injections and/or dermal fillers.
The primary objective of this study was to compare the efficacy of a new antiaging treatment (Purgenesis™) for which the principal ingredient is R-Spinasome ® , a thylakoid extract, to two marketed antiaging cosmetic products (Prevage ® and La Mer ® ). Secondary objectives included evaluation of consumer acceptance and tolerance of these products in normal use.
| MATERIAL S AND ME THODS
This single-centre, single-blind, parallel-design clinical study enrolled 72 healthy female volunteers aged 35-72 years (mean age 54.6 years)
with fine-to-moderate wrinkles in the lateral canthal areas ("crow's feet"). Assessments were conducted over 28 days (Table 1 ).
Based on Material Safety Data Sheets and toxicology information available from ingredient suppliers, the sponsor provided Certificates of Innocuity for each test product, confirming their suitability for use and conformity with Canadian regulations. The study received ethics approval. Each volunteer was informed verbally and in writing of the nature of the test and of the potential risks involved.
All volunteers provided informed consent to participate in the study, including consent to be photographed.
| Inclusion and exclusion criteria
Inclusion criteria for volunteers included females in good health aged 35 years or older with normal-to-dry skin on the face, fine-to-moderate 10 lines, and wrinkles in the lateral canthal areas, consistent usage of a method of contraception (eg, contraceptive pill, condoms, spermicidal creams, intrauterine device, abstinence), who were regular daily users of facial care products (to ensure they were sufficiently disciplined to follow a daily facial care routine, agreed to use only the test products in their daily facial routine, with the exception of their regular cleansing and makeup products. Patients were aware of the need for compliance with regular follow-up evaluations and tests in accordance with the established study protocol and signed informed consent forms with full knowledge of the details of the study and associated risks prior to study participation.
Exclusion criteria included previous usage of either of the comparator antiaging product lines, a history of skin irritation or allergies to the type of products to be tested (eg, antiaging products, eye serum, hydrating creams), a history of general allergies to certain food (including spinach), chemical products, glues, latex (rubber gloves) or jewelry, a history of severe acne, eczema, psoriasis, or significant skin anomalies on the areas to be tested, presence of a serious illness or health problem (eg, asthma, diabetes, cancer, immune deficiency, removed organ), use of prescription or over-the-counter medication at a frequency of ≥3 doses per week that could affect skin characteristics (eg, antibiotics, steroids, antihistamines, anti-inflammatories), within 7 days of study initiation, history or current significant skin pigmentation, regular use of tanning salons, or expectation of sun exposure during the study, history or current abuse of alcohol, drugs, or tobacco, and pregnancy, lactation, or plan to become pregnant during the study.
| Protocol and randomization
All volunteers were instructed to arrive at the initial visit (Day 0) ≥2 hours after completing their regular face-washing routine and without makeup or skin treatment on their faces. Those who satisfied the inclusion and exclusion criteria were randomized to a homogeneously labeled container containing day cream, night cream, and eye product corresponding to one (1) of the three ( Volunteers who entered into the study also received a follow-up sheet to be completed after every treatment application and a self-evaluation questionnaire to be completed after the 28-day course of treatment. The volunteers were instructed to apply the products each morning, after having washed their face and hands with their regular cleansing products. The eye cream/lotion/balm was the first product to be used, to be applied to the eye contours, including the lateral canthal areas. After the eye cream/lotion/balm was absorbed into the skin, the volunteers were to cover their entire face with the day cream, avoiding the eye contour area.
TA B L E 1 Study schedule
Every evening, the volunteers were to cover their entire face with the night cream, avoiding the eye contour area. The volunteers were not permitted to change the brand of their regular facial cleanser or makeup products during the week prior to the commencement of the study and during the study.
Before the volunteers applied their first treatment on Day 0, 12 digital photographs of the face (full front, right and left profiles, in four imaging modes: standard, cross-polarized, ultraviolet, and parallel-polarized) were taken using the Visia-CR Imaging System (Canfield Scientific Inc). After 15 minutes of stabilization in a controlled environment room (temperature 22 ± 3°C, relative humidity 30 ± 5%), skin elasticity, hydration, and profilometry were measured. These measurements were repeated at visits on Days 1, 7, and 28 ( Table 1) .
Volunteers were instructed to provide completed daily logs on Days 1, 7, and 28. They were also required to return the containers with the 
| Test methods

| Skin hydration
Skin hydration was measured with a Corneometer ® CM820 (Courage & Khazaka, Germany) equipped with a 49-mm probe. The probe was gently pressed against the skin in the eye contour area (pressure of 3.56 N), and the capacitance was recorded. Triplicate measurements were taken from 6 different sites on the face (forehead, temples, chin, under-eye areas, and cheeks) of each volunteer. Two measurements were taken from the middle of each cheek.
| Cutaneous elasticity
| Profilometry (anti-wrinkle effect)
Imprints (negatives of the skin surface) of the eye contour zones were obtained by applying silicone polymer onto the lateral canthal areas, with the volunteer in an upright sitting position. The polymer used for this study was silicone dental impression material (Silflo ® ; Flexico Developments Ltd., Potters Bar, England). Imprints of the lateral canthal lines were analyzed by a computerized digital image processing system coupled to Quantirides ® software (designed by Monaderm, Monaco) to obtain the skin topography. This standard technique is based on measuring the shadows cast when an incident light is inclined at an angle of 35° on the replica. Analyzed parameters included the total area of wrinkled skin, the number and the mean depth of the depressions due to the cutaneous relief, and the depth of deep and medium wrinkles. The wrinkles were differentiated by classes of depth (Class 1 for 0-55 µm, fine; Class 2: 55-110 µm, moderate; and Class 3: 110-800 µm, profound) before and after the treatment of a given product.
| Qualitative survey
One section of the self-evaluation questionnaire was designed to gauge the volunteers' perception of their treatment's cosmetic quality (sensory attributes) and overall performance after 28 days of treatment. The volunteers rated the test treatment characteristics of cosmetic quality on a 4-point scale from 0 ("Did not appreciate") to 3 ("Highly appreciated"). To assess the perception of the efficacy of the treatments after 28 days of application, the volunteers were to complete questions related to the reduction of wrinkles, skin softness, firmness, hydration, smoothness, evenness of complexion, healthier looking complexion, and skin color. The responses for each criterion, expressed as "A lot," "Moderately," and "Slightly," were combined.
They were also encouraged to enter personal comments at the end of the questionnaire.
| Treatment acceptance
Treatment acceptance was defined by the overall participation of the volunteers in the study and the level of tolerance to the treatment they received. Tolerance to the treatment was evaluated based on the presence and severity of any observed reactions according to evaluator comment and volunteer self-reporting in the questionnaire. 
| Statistical method
| RE SULTS
A total of 72 healthy volunteers were recruited: 42 in Group A, 15
in Group B, and 15 in Group C. All of the volunteers completed the study without incidence. Compliance was found to be good in all volunteers, as indicated by the average daily use of the test products. The quantity required for covering the eye contour area was less than that for the facial application of the day and night creams.
| Treatment efficacy
| Perception of sensory attributes
Tables 2-4 present the average Total Appreciated ratings (combined "Appreciated" and "Highly Appreciated" scores) of the cosmetic qualities for the eye cream/lotion/balm, day creams, and night creams, respectively, from the volunteer self-assessment questionnaires.
The overall levels of appreciation of the sensory attributes associated with the eye cream/lotion/balm, day creams, and night creams were very good for all treatments. Statistical analysis showed a significant difference between Group A and Group C.
| Perception of treatment efficacy
The results of the Qualitative survey are summarized as total percentage of positive responses in Table 5 . The efficacy scores were similar for Groups A and B for most parameters, with the exception of skin firmness (88% for Group A versus 100% for Group B; Figure 1 ).
Considerable differences were found between these 2 treatment groups and Group C, particularly for the criteria of softer skin, smoother skin, and more beautiful skin color. Student's t test calculated differences were found to be significant between Group A and Group C (P < 0.05) but not between Group B and Group C (P < 0.1).
| Skin hydration
Statistical analysis of the data revealed that the hydration of the skin for treatment Groups A and B was improved significantly (P < 0.01) at each follow-up appointment compared to Day 0 and at Day 28
for Group C (Figure 2 ). It is interesting to note the similar pattern between Group A and Group C, in which there was considerable improvement from Day 7 to Day 28, while also recognizing the significant difference in their improvements on Days 1 and 7. however, only the improvement seen in treatment Group A was statistically significant (P < 0.05).
| Elasticity
Ur/Ue represents the net elasticity or firmness that diminishes with age and is considered to be the most important parameter of the skin's elasticity. No significant changes in firmness at Day 1 and Day 7 were observed in the tested treatment groups; however, treatment Group A demonstrated a statistically significant increase of 5% in firmness by Day 28 (P < 0.05; Figure 6 ).
| Profilometry
The profilometry measurements of the wrinkles evaluated the total number, surface area, total length, and mean length of the wrinkles TA B L E 5 Overall scores for the perception of efficacy of the three antiaging treatments after 28 days of application (Figures 7-10 ). Group A experienced significant improvement (P < 0.01) in the total number of wrinkles on Day 1 but not at subsequent evaluations (Figure 7) . Improvements with Group B and Group C did not achieve statistical significance at any time point. Significant benefits with respect to the area of wrinkles (P < 0.01 on Days 1 and 28; Figure 8 ), total wrinkle length (P < 0.01
on Days 1 and 28; Figure 9 ), and mean wrinkle length (P < 0.05 on Days 1 and 7; P < 0.01 on Day 28; Figure 10 ) were also seen in Group A alone. As noted in Figure 14 , the digital photographs are additional support of visual evidence of product efficacy. 
| Tolerance
No adverse events or serious adverse events were observed during the study. As part of the questionnaire, the volunteers were asked to judge treatments tolerance by selecting "None," "Slight," "Moderate," or "High" for each of the intolerance criteria. The list of the intolerance criteria and the responses were expressed as the percentage of volunteers responding in each category after 28 days of treatment (Table 6 ).
Despite some numerical differences observed between the groups, all treatments were well tolerated by the majority of the participants. Reports of moderate and high levels of redness, itching, tightness, burning sensation, stinging, eye watering, and appearance of acne lesions (pimples) were numerically higher in Group B. Group A and Group C had no moderate and severe intolerance criteria with the exception of singing (2%) in Group A.
| D ISCUSS I ON
Oxidative stress (intra-and extracellular) secondary to UV exposure is among the most common factors associated with premature signs erythema, 13, 14 skin-surface oxidation, 15 stimulation of sebaceous gland function, 16 melanogenesis, 17, 18 and alteration of the dermal matrix. [19] [20] [21] Antioxidant-containing products have been shown to protect the skin from these harmful effects. 22 Antioxidants come in many forms, including vitamins A (retinol), B3
(niacinamide), C, and E, botanicals such as resveratrol, polyphenols, and flavonoids, and the body's own coenzymeQ10. More than 8,000 polyphenol compounds have been identified. 23 The main classes are flavonoids, phenolic acids, stilbenes, and lignans. 24 Polyphenols are associated with a host of health benefits, including reduction in the risk of cardiovascular disease, cancer, diabetes, infections, and asthma. 23 Several studies have also demonstrated the safety and effectiveness of topical application of polyphenols for the preservation of human skin cell longevity. [25] [26] [27] [28] [29] The current study employed several objective and self-reported measures to compare the experimental Purgenesis™ topical antiaging product line in development, including eye, day, and night creams, with two marketed product lines: Prevage ® and La Mer ® . The principal ingredient of Purgenesis™ is the patented R-Spinasome ® , a thylakoid extract with demonstrated antioxidant properties. 36, 37 Thylakoids play a key role in the safe processing and dissipation of harmful energy generated by the interaction of antioxidant complexcontaining photosynthetic cell extracts with ROS. 30, 31 Spinach is also a rich source of phenolic compounds. 32, 33 Prevage products are made with idebenone, a synthetic analogue of ubiquinone and a stable form Subjective feedback from volunteer questionnaires on the sensory attributes was highly positive for all three treatments. Total appreciation rates were generally higher for the Purgenesis™ treatments (86% for eye cream, 95% for day cream, and 94% for night cream) than for the Prevage ® (88%, 85%, and 87%, respectively) and
La Mer ® (88%, 80%, and 76%, respectively) products.
All treatments were well tolerated by the majority of the participants. Recipients of Purgenesis™ and La Mer ® products generally experienced less intolerance adverse effects than those using Prevage ® products. The Prevage ® group had numerically higher rates of moderate-high intolerance and significantly higher rates of slight discomfort than the Purgenesis™ and La Mer ® groups.
| CON CLUS IONS
Benefits were observed with all three antiaging treatments tested in this study according to subjective and objective parameters. Specifically, the three treatments were shown to be effective in hydrating the skin. Only the treatment used by Group A (Purgenesis™ antiaging treatment) significantly improved elasticity and profilometry parameters during a study period of 28 days. The combined effect of improved parameters may be considered as an antiaging effect, and the Purgenesis™ treatment may be considered an effective treatment to counter the cutaneous signs and symptoms of aging. A longer-term study is recommended to further elucidate the maximal effects on elasticity and profilometric parameters.
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